| Literature DB >> 36110127 |
Aster Wakjira Garedow1, Gorfineh Teshome Tesfaye2.
Abstract
Background: One of the biggest emerging public health issues is the alarming increase in the prevelance of antibiotic resistance across the globe, which is linked to significant morbidity and mortality and demands special attention. The most significant risk factor for antimicrobial resistance (AMR), which is increasing considerably in Ethiopia and is responsible for increased adverse effects, treatment failure, and rising health-care costs, is inappropriate antibiotic usage. The purpose of this study was to assess the use of antibiotics in inpatient settings at an Ethiopian teaching hospital providing tertiary care.Entities:
Keywords: Jimma university; antibiotics; evaluation; pediatrics
Year: 2022 PMID: 36110127 PMCID: PMC9469905 DOI: 10.2147/IDR.S381999
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.177
Study Participants’ Baseline Characteristics and Other Related Information at the JUMC Pediatric Ward from November 1, 2021 to April 30, 2021
| Variables | Frequency | Percentage | |
|---|---|---|---|
| Age | <1 month | 91 | 22.63 |
| 1 month–1 year (infant) | 109 | 27.11 | |
| 1–5 years | 132 | 32.83 | |
| 6–18 years | 70 | 17.41 | |
| Duration of hospital stay (days) | ≤7 days | 107 | 26.62 |
| >7 days | 285 | 70.89 | |
| Sex | Male | 222 | 55.22 |
| Female | 180 | 44.78 | |
| Antibiotic treatment days | ≤7 days | 175 | 43.53 |
| >7 days | 227 | 56.47 | |
| Number of antibiotics prescribed | Monotherapy | 481 | 72.33 |
| Dual antibiotics | 115 | 17.3 | |
| Three antibiotics | 69 | 10.37 | |
| Prescriber | Medical intern | 340 | 51.13 |
| Senior | 64 | 9.6 | |
| Resident | 261 | 39.27 | |
| Treatment type | Empirical treatment | 351 | 60.41 |
| Kinetic/definitive treatment | 135 | 23.23 | |
| Prophylactic treatment | 95 | 16.35 | |
| Residence | Urban | 114 | 28.36 |
| Rural | 288 | 71.64 | |
| Weight (kg) | <4.9 | 63 | 15.67 |
| 5–9.9 | 156 | 38.8 | |
| 10–14.9 | 71 | 17.66 | |
| 15–19.9 | 48 | 11.94 | |
| >20 | 64 | 15.92 | |
Primary Infectious Conditions for which Antibiotics were Prescribed at Pediatric Ward of JUMC from November 1, 2021 to April 30, 2021 (N=485)
| Disease/Disorder Type | Frequency | Percentage |
|---|---|---|
| Meningitis | 162 | 33.4 |
| Lower respiratory tract infection | 137 | 28.24 |
| Severe pneumonia | 81 | 16.7 |
| Severe acute malnutrition | 77 | 15.86 |
| Late onset neonatal sepsis | 42 | 8.66 |
| Early onset neonatal sepsis | 29 | 5.97 |
| Skin and soft tissue infection | 22 | 4.53 |
| Unknown | 16 | 3.3 |
| Total | 485 | 100 |
Most Commonly Prescribed Individual Antibiotics at the Pediatric Ward of JUMC from November 1, 2021 to April 30, 2021 (N=481)
| Antimicrobial Agents | Frequency | Percentage |
|---|---|---|
| Gentamycin | 116 | 24.11 |
| Penicillin G | 87 | 18.1 |
| Ampicillin | 82 | 17 |
| Ceftriaxone | 73 | 15.17 |
| Cloxacillin | 58 | 12.06 |
| Chloramphenicol | 53 | 11,02 |
| Metronidazole | 39 | 8.1 |
| Amoxicillin | 29 | 6.02 |
| Ceftazidime | 24 | 4.98 |
| Azithromycin | 10 | 2.01 |
| Total | 481 | 100 |
Most Commonly Prescribed Combination Antibiotics at the Pediatric Ward of JUMC from November 1, 2021 to April 30, 2021 (N=184)
| Antimicrobial Combinations | Frequency | Percentage |
|---|---|---|
| Ampicillin+gentamycin | 66 | 43.33 |
| Ceftriaxone+gentamycin | 33 | 17.93 |
| C.pencillin G+chloramphenicol | 25 | 13.9 |
| Ampicillin+gentamycin+metronidazole | 23 | 12.5 |
| Ceftriaxone+metronidazole | 18 | 9.7 |
| Ampicillin+gentamycin+metronidazole | 13 | 2.85 |
| Ceftriaxone+ampicillin | 3 | 1.63 |
| Ceftriaxone+gentamycin+cloxacillin | 3 | 1.63 |
| Total | 184 | 100 |
Route of Drug Administration Among Pediatric Patient of JUMC Pediatric Ward from November 1, 2021 to April 30, 2021 (N=665)
| Route | Frequency | Percentage |
|---|---|---|
| Parenteral (IV, IM) | 523 | 78.65 |
| PO | 142 | 21.35 |
| Total | 665 | 100 |
Appropriateness of Dosage Regimen of Overall Antibiotics Prescribed at the Pediatric Ward of JUMC from November 1, 2021 to April 30, 2021 (N=665)
| Parameters | Antibiotic Regimen | Number | Percentage |
|---|---|---|---|
| Dose | Appropriate | 535 | 80.45 |
| Inappropriate | 130 | 19.55 | |
| Frequency | Appropriate | 516 | 77.59 |
| Inappropriate | 149 | 22.41 | |
| Duration | Appropriate | 540 | 81.2 |
| Inappropriate | 125 | 18.8 | |
| Treatment | Appropriate | 536 | 80.6 |
| Unnecessary antibiotic | 129 | 19.4 |
Factors Associated with Inappropriate Use of Antibiotics Using Binary Logistic Regression at the Pediatric Ward of JUMC from November 1, 2021 to April 30, 2021
| Variables | Appropriateness | COR (95%CI) | AOR (95%CI) | ||||
|---|---|---|---|---|---|---|---|
| Yes | No | ||||||
| Age | <1 month | 51 | 49 | 1 | 0.55 | ||
| 1 month–1 year (infant) | 61 | 46 | 0.34 (1.23–2.45) | 0.76 | |||
| 1–5 years | 98 | 34 | 0.65 (2.43–5.23) | 0.75 | |||
| 6–18 years | 50 | 20 | 0.54 (3.21–6.23) | 0.45 | |||
| Duration of hospital stay (days) | ≤7 days | 72 | 45 | 1 | 0.24 | 1 | 0.03 |
| >7 days | 217 | 68 | 2.45 (2.32–5.34) | 0.05 | 2.21 (2.32–7.64) | ||
| Sex | Male | 153 | 69 | 0.12 (2.56–4.87 | 0.78 | ||
| Female | 132 | 48 | 1 | ||||
| Antibiotic treatment days | ≤7 days | 127 | 48 | 1 | 0.23 | 1 | 0.02 |
| >7 days | 130 | 97 | 2.23 (3.34–5.54) | 0.03 | 2.54 4.34–6.54) | ||
| Number of antibiotics prescribed | 1 | 332 | 149 | 1 | 0.084 | 1 | 0.01 |
| ≥2 | 115 | 69 | 2.37 (5.32–12.65) | 0.02 | 3.12 (6.32–13.37) | ||
| Prescriber | Medical intern | 288 | 52 | 1 | 0.26 | ||
| Senior | 44 | 20 | 0.84 (2.65–5.63) | 0.45 | |||
| Resident | 188 | 73 | 1.32 (4.32–7.82) | 0.74 | 1 | ||
| Treatment type | Kinetic/definitive treatment | 88 | 47 | 1 | 0.24 | 1 | 0.34 |
| Empirical treatment | 299 | 52 | 2.21 (3.42–6.84) | 0.02 | 2.65 (4.23–8.87) | 0.04 | |
| Prophylactic treatment | 55 | 40 | 0.91 (4.62–7.74) | 0.17 | 3.12 (6.32–10.23) | 0.08 | |
| Residence | Urban | 74 | 40 | 1 | 0.64 | ||
| Rural | 231 | 57 | 0.45 (2.32–6.73) | 0.72 | |||
| Weight (kg) | <4.9 | 42 | 21 | 1 | 0.84 | ||
| 5–9.9 | 108 | 48 | 1.23 (2.76–5.63) | 0.52 | |||
| 10–14.9 | 40 | 31 | 0.93 (3.21–5.65) | 0.63 | |||
| 15–19.9 | 25 | 23 | 0.32 (2.73–6.74) | 0.74 | |||
| >20 | 38 | 26 | 0.84 (1.74–4.54) | 0.73 | |||